SB204: Ph III NI-AC301 and NI-AC302 data

Top-line data from the identical, double-blind, placebo-controlled, U.S. Phase III NI-AC301 and NI-AC302 trials in a total of 2,639 patients ages ≥9 with moderate to severe acne showed that once-daily...